We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Test the Value of a Pain Modulation Test in Predicting Persistent Postoperative Pain After Breast Cancer Surgery (PREDO)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01767168
First Posted: January 14, 2013
Last Update Posted: August 1, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Benno Rehberg-Klug, University Hospital, Geneva
  Purpose
The purpose of this study is to test the hypothesis that a preoperative test of pain modulation predicts persistent pain 4 months after breast cancer surgery. In addition, a risk score for the prediction of persistent pain will be developed from parameters available before surgery.

Condition Intervention
Chronic Pain Acute Pain Other: comprehensive preoperative testing for risk factors of persistent postoperative pain

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Trial of Diagnostic Accuracy for the Prediction of Persistent Postoperative Pain After Breast Cancer Surgery Using a Conditioned Pain Modulation Test

Resource links provided by NLM:


Further study details as provided by Benno Rehberg-Klug, University Hospital, Geneva:

Primary Outcome Measures:
  • prevalence of pain at the site of surgery [ Time Frame: 4 months postop ]
    clinically important pain defined as either necessitating analgesic treatment or having an intensity of more than 3/10 at rest or 5/10 on movement, at 4 months after surgery


Secondary Outcome Measures:
  • acute pain [ Time Frame: 24h ]
    maximum pain >3/10

  • subacute pain [ Time Frame: 1 week ]
    average pain, maximum pain >2

  • prevalence of pain necessitating analgesics at the site of surgery [ Time Frame: 4 months ]
  • prevalence of pain at the site of surgery [ Time Frame: 8 months ]
  • prevalence of pain at the site of surgery [ Time Frame: 12 months ]

Biospecimen Retention:   Samples With DNA
venous blood sample

Enrollment: 200
Study Start Date: May 2011
Study Completion Date: May 2016
Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: comprehensive preoperative testing for risk factors of persistent postoperative pain
    nociceptive reflex threshold, pain threshold, CPM-effect of hot water bath, pain sensitivity questionnaire, STAI, BDI, fear of surgical consequences
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
women scheduled for any type of breast cancer surgery in a university hospital breast cancer center
Criteria

Inclusion Criteria:

  • age >=18 years
  • American Society of Anesthesiology functional status I-III
  • able to read and understand the information sheet and give informed consent

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01767168


Locations
Switzerland
Hôpitaux Universitaires de Genève
Geneva, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Principal Investigator: Benno Rehberg-Klug, MD Dept of Anesthesiology, HUG
  More Information

Responsible Party: Benno Rehberg-Klug, médecin adjoint agrégé, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT01767168     History of Changes
Other Study ID Numbers: CER 10-218
matped 10-054 ( Other Identifier: local ethics committee )
First Submitted: January 10, 2013
First Posted: January 14, 2013
Last Update Posted: August 1, 2016
Last Verified: July 2016

Additional relevant MeSH terms:
Pain, Postoperative
Chronic Pain
Acute Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms